Skip to main content
Erschienen in: Indian Journal of Surgical Oncology 1/2023

02.02.2023 | Original Article

Invasive Micropapillary Urothelial Carcinoma: an Uncommon and Underreported Variant in Cystectomy Specimens

verfasst von: Pallavi Prasad, Harshita Baranwal, Vinita Agrawal

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Conventional urothelial carcinoma is the most common histological type of urinary bladder carcinoma. The latest edition of the WHO classification of tumours of the urothelial tract lays special emphasis on the ability of urothelial tumours to exhibit divergent differentiation with multiple histologic variants and a diverse genomic landscape. The presence of a micropapillary component (MPC) in urothelial carcinoma is associated with high-grade disease and poor response to intravesical chemotherapy. The present study aims to enumerate the clinicohistological features of urothelial carcinomas with micropapillary differentiation. Slides from 144 radical cystectomy specimens received over 6 years were reviewed independently by two pathologists. A predominant histological pattern along with co-existing pathology was noted. Of these, five cases were pure micropapillary carcinomas, four had conventional urothelial carcinoma with a MPC, one had a microscopic tumour at the mucosal surface, and two cases showed micropapillary histology in the lymph node metastasis, following transurethral resection of bladder tumour and Bacillus Calmette-Guerin therapy. The tumours with pure micropapillary carcinoma presented with a higher pathological stage and poor overall survival. Organ and lymph node metastasis was noted in five and eight cases, respectively, of which six showed a micropapillary pattern in the lymph nodes. Micropapillary urothelial carcinoma is a rare and aggressive variant of urothelial carcinoma with unique histologic features. This variant is often missed and underreported in biopsy and surgical resection specimens. Since the presence of MPC confers a poorer prognosis, the identification and reporting of this entity are important.
Literatur
1.
Zurück zum Zitat Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249CrossRefPubMed
2.
Zurück zum Zitat Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol 70(1):106–119CrossRefPubMed Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol 70(1):106–119CrossRefPubMed
3.
Zurück zum Zitat Hsu J, Ro J (2019) Micropapillary carcinoma of the bladder: recent advances. Annals Urologic Oncol 7:1–10 Hsu J, Ro J (2019) Micropapillary carcinoma of the bladder: recent advances. Annals Urologic Oncol 7:1–10
4.
Zurück zum Zitat Amin MB, Ro JY, el-Sharkawy T, Lee KM, Troncoso P, Silva EG, Ordóñez NG, Ayala AG (1994) Micropapillary variant of transitional cell carcinoma of the urinary bladder Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 18(12):1224–32CrossRefPubMed Amin MB, Ro JY, el-Sharkawy T, Lee KM, Troncoso P, Silva EG, Ordóñez NG, Ayala AG (1994) Micropapillary variant of transitional cell carcinoma of the urinary bladder Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 18(12):1224–32CrossRefPubMed
5.
Zurück zum Zitat Samaratunga H, Khoo K (2004) Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 45(1):55–64CrossRefPubMed Samaratunga H, Khoo K (2004) Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 45(1):55–64CrossRefPubMed
6.
Zurück zum Zitat Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL (2007) Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 110(1):62–7CrossRefPubMed Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL (2007) Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 110(1):62–7CrossRefPubMed
7.
Zurück zum Zitat Meeks JJ, Taylor JM, Matsushita K, Herr HW, Donat SM, Bochner BH, Dalbagni G (2013) Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. BJU Int 111(8):E325-30CrossRefPubMed Meeks JJ, Taylor JM, Matsushita K, Herr HW, Donat SM, Bochner BH, Dalbagni G (2013) Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. BJU Int 111(8):E325-30CrossRefPubMed
8.
Zurück zum Zitat Sui W, Matulay JT, James MB, Onyeji IC, Theofanides MC, RoyChoudhury A, DeCastro GJ, Wenske S (2016) Micropapillary bladder cancer: insights from the National Cancer Database. Bladder Cancer 2(4):415–423CrossRefPubMedPubMedCentral Sui W, Matulay JT, James MB, Onyeji IC, Theofanides MC, RoyChoudhury A, DeCastro GJ, Wenske S (2016) Micropapillary bladder cancer: insights from the National Cancer Database. Bladder Cancer 2(4):415–423CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Cheng YT, Luo HL, Sung MT, Chiang PH (2010) Micropapillary variant of urothelial carcinoma: a report of 4 cases and literature review. Chang Gung Med J 33(4):461–5PubMed Cheng YT, Luo HL, Sung MT, Chiang PH (2010) Micropapillary variant of urothelial carcinoma: a report of 4 cases and literature review. Chang Gung Med J 33(4):461–5PubMed
10.
Zurück zum Zitat Perepletchikov AM, Parwani AV (2009) Micropapillary urothelial carcinoma: clinico-pathologic review. Pathol Res Pract 205(12):807–10CrossRefPubMed Perepletchikov AM, Parwani AV (2009) Micropapillary urothelial carcinoma: clinico-pathologic review. Pathol Res Pract 205(12):807–10CrossRefPubMed
11.
Zurück zum Zitat Lopez-Beltran A, Montironi R, Blanca A, Cheng L (2010) Invasive micropapillary urothelial carcinoma of the bladder. Hum Pathol 41(8):1159–64CrossRefPubMed Lopez-Beltran A, Montironi R, Blanca A, Cheng L (2010) Invasive micropapillary urothelial carcinoma of the bladder. Hum Pathol 41(8):1159–64CrossRefPubMed
13.
Zurück zum Zitat Compérat E, Roupret M, Yaxley J, Reynolds J, Varinot J, Ouzaïd I, Cussenot O, Samaratunga H (2010) Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases. Pathology 42(7):650–4CrossRefPubMed Compérat E, Roupret M, Yaxley J, Reynolds J, Varinot J, Ouzaïd I, Cussenot O, Samaratunga H (2010) Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases. Pathology 42(7):650–4CrossRefPubMed
14.
Zurück zum Zitat Monn M, Cheng L (2016) Evolving concepts of micropapillary variant urothelial carcinoma. Transl Cancer Res 5(S7):S1539–S1542CrossRef Monn M, Cheng L (2016) Evolving concepts of micropapillary variant urothelial carcinoma. Transl Cancer Res 5(S7):S1539–S1542CrossRef
15.
Zurück zum Zitat Hui Y, Lombardo KA, Quddus MR, Matoso A (2018) Cell polarity reversal distinguishes true micropapillary growth from retraction artifact in invasive urothelial carcinoma. Appl Immunohistochem Mol Morphol 26(1):e1–e6CrossRefPubMed Hui Y, Lombardo KA, Quddus MR, Matoso A (2018) Cell polarity reversal distinguishes true micropapillary growth from retraction artifact in invasive urothelial carcinoma. Appl Immunohistochem Mol Morphol 26(1):e1–e6CrossRefPubMed
16.
Zurück zum Zitat Sangoi AR, Higgins JP, Rouse RV, Schneider AG, McKenney JK (2009) Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact. Mod Pathol 22(5):660–7CrossRefPubMed Sangoi AR, Higgins JP, Rouse RV, Schneider AG, McKenney JK (2009) Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact. Mod Pathol 22(5):660–7CrossRefPubMed
17.
Zurück zum Zitat Chatterjee D, Das A, Radotra BD (2015) Invasive micropapillary carcinoma of urinary bladder: a clinicopathological study. Indian J Pathol Microbiol 58(1):2–6CrossRefPubMed Chatterjee D, Das A, Radotra BD (2015) Invasive micropapillary carcinoma of urinary bladder: a clinicopathological study. Indian J Pathol Microbiol 58(1):2–6CrossRefPubMed
Metadaten
Titel
Invasive Micropapillary Urothelial Carcinoma: an Uncommon and Underreported Variant in Cystectomy Specimens
verfasst von
Pallavi Prasad
Harshita Baranwal
Vinita Agrawal
Publikationsdatum
02.02.2023
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 1/2023
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-022-01692-7

Weitere Artikel der Ausgabe 1/2023

Indian Journal of Surgical Oncology 1/2023 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.